Latest News:

ar deelen fr it

TIF

TIF’s latest Newletter is out now!

Catch up with our most recent newsletter and get informed about TIF’S activities and achieveme...
LOVING LIFE ENOUGH by Mary Manachi

This is the story of the late Mrs. Mary Manachi from New Jersey, USA, who lost 3 children from thala...
Bluebird bio announces 1st commercial launch of ZYNTEGLO™in Germany

Bluebird bio, Inc. announced earlier today the launch of ZYNTEGLO™ in Germany, the company&...
Deferasirox Accord: A new generic of Exjade recommended for approval by the EMA

The Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency‘ (EMA...
FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease

Global Blood Therapeutics, Inc. announced only a few hours ago that the U.S. Food and Drug Ad...

Highlights

TIF e-AcademyAcadémie électronique de la FITe-Academyالأكاديمية الإلكترونية للاتحاد الدولي للثلاسيمياΗλεκτρονική ΑκαδημίαTIF e-Akademie

Patients' StoriesRécits de patientsStorie di pazientiقصص المرضىΙστορίες ΑσθενώνErfahrungsberichte von Patienten

Clinical Trial UpdatesEssais cliniques - Mises à jourAggiornamenti sugli studi cliniciآخر مستجدات التجارب الإكلينكية Ενημερώσεις για κλινικές δοκιμέςUpdate zu klinischen Studien

Renzo Galanello FellowshipsBourses Renzo GalanelloBorsa di studio Renzo Galanelloمنحة رينزو جالانيلوΥποτροφίες Renzo GalanelloRenzo Galanello Stipendien

International Thalassaemia DayJournée Mondiale de la ThalassémieGiornata internazionale della talassemiaاليوم العالمي ’للثلاسيميا’Παγκόσμια Ημέρα ΘαλασσαιμίαςInternationaler Tag der Thalassämie

The THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA Project

Supporters Sympathisants Sostenitori الداعمون Οι Υποστηρικτές μας Unterstützer